Author/Authors :
Hosseini، Pooria نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA , , Mundis Jr، Gregory M نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA , , Eastlack، Robert نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA , , Pawelek، Jeff نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA , , Nguyen، Stacie نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA , , Akbarnia، Behrooz A. نويسنده Orthopedic Department,San Diego Center for Spinal Disorders,San Diego,USA ,
Abstract :
Background Ultrasonic bonecutting devices (UBC) are new cutting tools and have low frequency ultrasonic blade. There is limited data on the safety and effectiveness of using ultrasonic bonecutting devices in the treatment of adult spinal deformities (ASD). Objectives This Retrospective review of prospectively collected data was designed to determine if the use of an ultrasonic bonecutting device is safe in the adult spinal deformity population and to compare its effectiveness in blood loss reduction by using a comparison group from a prospective multicenter database of adult spinal deformity patients. Methods Nineteen consecutive surgical ASD cases in which the UBC was used were compared with 19 propensitymatched cases from a prospective ASD database in which conventional bone cutting instruments were used. The two groups were matched based on age, ASA, and number of levels fused posteriorly. The need for blood transfusion, volume of blood transfusion if required, estimated blood loss (EBL), and total operating time were compared between the two groups. Data were analyzed using nonparametric MannWhitney U test and Spearman’s Correlation test (P < 0.05). Results There was no statistically significant difference in any measured parameter between the two groups. While the EBL difference between the two groups (925 mL in the study group vs. 1628 mL in the control group) was not statistically significant (P = 0.142), the 703 mL difference is clinically relevant. In addition, no complications directly related to the use of the UBC were reported. Conclusions The use of an ultrasonic bonecutting device was shown to be safe and effective in the surgical treatment of ASD. It resulted in a 43% reduction in EBL, which was clinically relevant and statistically nonsignificant, without the addition of any complications. We did not identify statistical differences in transfusion rates, EBL, or operative time, which may be due to our small sample size.
Keywords :
Adult Spine Deformity , Bone Scalpel , Ultrasonic BoneCutting Device , Blood loss
